25 of the Best Oncologists Near Me in berkeley, CA

Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Porten is board certified in American Board Of Urology, Urology. Dr. Porten is currently accepting new patients.

Dr. Madhulika (Mika) Varma, chief of colorectal surgery at UCSF Medical Center, specializes in diseases of the colon, rectum and anus. Her areas of expertise include colorectal and anal cancer, inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and pelvic floor disorders. She also is a specialist in treating many of these diseases using laparoscopic (minimally invasive) surgical techniques. Varma is director of the Center for Pelvic Physiology, which evaluates patients with fecal incontinence, constipation, rectal cancer and anal fistula. She is co-director of the UCSF Center for Inflammatory Bowel Disease and a member of the Women's Continence Center and Women's Health Clinical Research Center. Varma's research interests include clinical outcomes for inflammatory bowel diseases and defecation disorders. Varma earned her medical degree at the Warren Alpert Medical School of Brown University. She completed a residency in general surgery at UCSF and spent a year at the University of Minnesota for specialized training in colon and rectal surgery. In 2000, she returned to UCSF, where she completed a fellowship in clinical outcomes research and epidemiology. Dr. Varma is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Crohn's Disease, Colorectal Cancer, Hernia Surgery, and Bladder Reconstruction. Dr. Varma is board certified in American Board Of Colon And Rectal Surgery, Colon & Rectal Surgery and American Board Of Surgery, General Surgery. Dr. Varma is currently accepting new patients.

Dr. R. Kate Kelley is a gastrointestinal oncologist who treats liver cancers such as hepatocellular carcinoma; bile duct cancer (cholangiocarcinoma); gastric cancer; esophageal cancer; anal, colon and rectal cancer; pancreatic cancer; and gastrointestinal stromal tumors. Kelley's research interests include developing clinical trials to identify new treatments for gastrointestinal malignancies, particularly hepatocellular carcinoma and bile duct cancer. Kelley graduated from the David Geffen School of Medicine at UCLA and completed a residency at UCLA, where she was chief resident in internal medicine. She also completed a fellowship in hematology and oncology at UCSF. Kelley received the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Merit Award in 2009 and the ASCO Young Investigator Award in 2010. She co-authored a chapter on digestive tract cancers in the textbook Current Medical Diagnosis and Treatment. Dr. Kelley is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Fibrolamellar Carcinoma, Gallbladder Cancer, and Tissue Biopsy. Dr. Kelley is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Kelley is currently accepting new patients.

Kevin Knopf is an Oncologist practicing medicine in Berkeley, California. Dr. Knopf is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Knopf is board certified in Medical Oncology. Dr. Knopf is currently accepting new patients.

Ashutosh Lal is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Lal is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Elliott Vichinsky is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vichinsky is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Mark Walters is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Walters is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Hemoglobinopathy, Congenital Hemolytic Anemia, Sickle Cell Disease, Hemolytic Anemia, and Bone Marrow Transplant.

Sylvia Singer is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Singer is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Thalassemia, Beta Thalassemia, Hemoglobinopathy, Congenital Hemolytic Anemia, and Splenectomy.

Carolyn Hoppe is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Hoppe is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

James Feusner is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Feusner is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Hepatoblastoma, Acute Myeloid Leukemia (AML), and Leukemia.

Caring, compassionate, and patient centric care. Dr. Quock is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Quock is currently accepting new patients.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

John Chan is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chan is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy. Dr. Chan is board certified in Obstetrics And Gynecology - Board Certified , OB & Gyn (Sub: Gynecologic Oncology), Gynecologic Oncology - Board Certified, and Obstetrics & Gynecology. Dr. Chan is currently accepting new patients.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Meng is board certified in American Board Of Urology, Urology. Dr. Meng is currently accepting new patients.

Dr. Chienying Liu is an endocrinologist who cares for patients with thyroid cancer, thyroid nodules and other thyroid disorders. She also cares for patients with endocrine neoplasia (tumors of hormone producing glands, such as adrenal tumors, pheochromocytomas, paragangliomas, parathyroid tumors, and pituitary tumors). Liu has research interests in thyroid cancer and adrenal disorders. Liu earned her medical degree from the University of Pittsburgh. She completed a residency in internal medicine at the University of Rochester. She completed her fellowship in diabetes, endocrinology and metabolism at UCSF. Liu is a member of the Endocrine Society and American Thyroid Association. She enjoys teaching medical students, residents and fellows. She received the John Karam MD Clinician Educator Award in 2014. In her free time, Liu enjoys active travel and believes that traveling and seeing the world make us better human beings. Dr. Liu is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Thymectomy. Dr. Liu is board certified in American Board Of Internal Medicine, Endocrinology Diabetes & Metab. Dr. Liu is currently accepting new patients.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy. Dr. Bergsland is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Bergsland is currently accepting new patients.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy. Dr. Koshkin is board certified in American Board Of Internal Medicine, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Koshkin is currently accepting new patients.

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments. Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF. Dr. Blakely is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Blakely is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Blakely is currently accepting new patients.

Dr. Peter Carroll is a surgeon specializing in urological oncology. He is internationally known for his expertise in managing patients with cancers of the urinary system. In research, Carroll's areas of interest include early detection and patient-centered management of urological cancers, most notably prostate cancer. He is principal investigator or co-investigator of many studies that received peer-reviewed research grants as well as author or co-author of more than 700 publications. Carroll earned his medical degree from Georgetown University School of Medicine, graduating with honors. He completed training in general surgery and a residency in urology at UCSF. He completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center before returning to UCSF. He also has a master of public health degree from the University of California, Berkeley. At UCSF, he holds both the Ken and Donna Derr-Chevron and Taube Family distinguished professorships. Dr. Carroll is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Reconstructive Urology Surgery. Dr. Carroll is board certified in American Board Of Urology, Urology. Dr. Carroll is currently accepting new patients.

Dr. Hala Borno is a medical oncologist who cares for patients who have cancers along the urinary tract, including kidney, bladder, testicular and prostate cancer. She specializes in treating prostate cancer. Borno's research focuses on improving access to cancer clinical trials and digital health innovation. Borno earned her medical degree from the University of North Carolina at Chapel Hill School of Medicine. She completed a residency in internal medicine and a fellowship in medical oncology at UCSF, where she was selected chief oncology fellow. She is a member of the American Society of Clinical Oncology and Alliance for Clinical Trials in Oncology. Dr. Borno is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), and Orchiectomy. Dr. Borno is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Borno is currently accepting new patients.

Christopher Dvorak is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Dvorak is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Primary Immunodeficiency (PID), Bone Marrow Transplant, and Splenectomy.

Dr. Michelle E. Melisko is a cancer specialist with expertise in caring for patients with breast cancer. Also active in research, Melisko is interested in evaluating new chemotherapy combinations, biological therapies and immunotherapies for breast cancer, with a particular focus on treating cancer that has spread to the brain. To foster more rapid advances in breast cancer treatment, she educates patients on clinical trials and encourages them to participate when appropriate. Melisko earned her medical degree at the Wake Forest School of Medicine and completed a residency in internal medicine at Stanford Medicine. She completed a fellowship in hematology and oncology at UCSF. Dr. Melisko is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Melisko is board certified in American Board Of IM/Hospice & Palliative Medicine, Hospice & Palliative Medicine and American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Melisko is currently accepting new patients.

Eric Collisson is an Oncologist practicing medicine in San Francisco, California. Dr. Collisson is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Tissue Biopsy, and Pancreatectomy. Dr. Collisson is currently accepting new patients.

Dr. John Gordan is a gastrointestinal cancer specialist who cares for patients with hepatobiliary cancers, such as cholangiocarcinoma (bile duct cancer), hepatocellular carcinoma (the most common liver cancer) and gallbladder cancer. Gordan is actively involved in designing and carrying out clinical trials of potential treatments for hepatocellular carcinoma and cholangiocarcinoma. His laboratory research focuses on identifying new therapies for patients with these cancers as well as identifying predictive biomarkers to better apply existing therapies. Gordan completed his medical degree at the University of Pennsylvania, followed by a residency in internal medicine and a fellowship in medical oncology at UCSF. He joined the UCSF faculty in 2015. Gordan is a member of the American Society of Clinical Oncology, which supports his research, as does the American Cancer Society. Dr. Gordan is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, Gallbladder Cancer, and Tissue Biopsy. Dr. Gordan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gordan is currently accepting new patients.

Dr. Margaret Tempero is a gastrointestinal oncologist and the director of the UCSF Pancreas Center and leader of the Pancreas Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center. In research, Tempero was a pioneer in applying radioactively tagged antibodies for cancer therapy. She has led national research projects on gastrointestinal cancers, including pancreatic cancer. Tempero has held editorial positions on such prestigious journals as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Medicine. She is the Rombauer Family Distinguished Professor in Pancreas Cancer Clinical and Translational Science. Prior to joining UCSF, she was deputy director of the University of Nebraska's cancer center. Dr. Tempero is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatoblastoma, and Pancreatectomy. Dr. Tempero is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Med/Medical Oncology, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Tempero is currently accepting new patients.